Advanced Medical Solutions Grp PLC Notice of Annual General Meeting and Annual Report (5171E)
May 08 2017 - 12:10PM
UK Regulatory
TIDMAMS
RNS Number : 5171E
Advanced Medical Solutions Grp PLC
08 May 2017
8 May 2017
Advanced Medical Solutions Group plc
("AMS" or the "Company")
Annual Report and Accounts for the year ended 31 December
2016 and Notice of AGM
Winsford, UK, 8 May: Advanced Medical Solutions Group plc (AIM:
AMS), the surgical and advanced wound care specialist company, is
pleased to announce that in accordance with AIM Rules 20 and 26,
the Annual Report and Financial Statements for the year ended 31
December 2016 were posted to shareholders today and are available
on the Investor Relations section of the Company's website
https://www.admedsol.com/investor-relations/.
The notice of meeting convening the Annual General Meeting of
the Company, which will be held on 7 June 2017 at 11 am at the
offices of Investec Bank plc, 2 Gresham Street, London, EC2V 7QP,
was also posted to shareholders today and is available on the
Company's website.
- Ends -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Chief Finance Officer
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Jonathan
Birt / Matthew Neal / Hendrik
Thys
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Daniel Adams / Patrick Robb
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical and wound care markets, focused on quality outcomes for
patients and value for payors. AMS has a wide range of wound care
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it sells under white label
as well as its own brand ActivHeal(R) , and surgical tissue
adhesives, sutures and haemostats, which markets under its own
brands; LiquiBand(R) and RESORBA(R) .
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 70 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Company has 600 employees. For more
information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCAPMFTMBMMBFR
(END) Dow Jones Newswires
May 08, 2017 12:10 ET (16:10 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024